Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
Health Technology » Pharmaceuticals Major
|JNJ||Johnson & Johnson||-0.05%||179.46||0.7%||$1295.87m|
|BMY||Bristol-Myers Squibb Co.||0.00%||77.59||1.0%||$1212.16m|
|MRK||Merck & Co., Inc.||-0.20%||92.14||0.7%||$1164.75m|
|LLY||Eli Lilly & Co.||0.19%||314.08||1.1%||$969.13m|
|BHVN||Biohaven Pharmaceutical Holding Co. Ltd.||-0.14%||142.98||0.0%||$491.89m|
|HZNP||Horizon Therapeutics Plc||2.20%||92.58||5.4%||$200.34m|
|NVO||Novo Nordisk A/S||-0.58%||106.00||0.1%||$181.83m|
Viatris, Inc. is a global healthcare company, which engages in the provision of access to medicines and sustainable operations. It also offers support services such as diagnostic clinics, educational seminars, and digital tools. The firm operates through the following segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The Developed Markets segment consists of operations primarily in North America and Europe. The Greater China segment includes operations in mainland China, Taiwan and Hong Kong. The JANZ segment consists of operations in Japan, Australia and New Zealand. The Emerging Markets segment encompasses operations with developing markets and emerging economies including countries in Asia, the Middle East, South and Central America, Africa and Eastern Europe. The company was founded on February 14, 2019 and is headquartered in Canonsburg, PA.